The move comes in response to growing American and Canadian investments in facilities to increase domestic production.

Intel Corporation is set to face intense investor scrutiny over its ongoing CEO search and turnaround strategy as it prepares to report quarterly earnings on Thursday. The company is grappling with ...

Advanced Therapeutics Pharmaceutical Outsourcing IndustryFuture Market Insights (FMI), a leading provider of industry analysis and market research, has unveiled its latest report highlighting the ...

The beauty industry is in the midst of a significant transformation, with contract manufacturing emerging as a key driver for ...

Lonza Group has been a dominant player in the contract development and manufacturing space for decades. We think the outlook for Lonza looks bright, especially as drug manufacturing becomes more ...

One positive of the last election is that the Trump administration is pro-US manufacturing and is considering tax incentives to reward companies that manufacture in the US and tariffs to punish ...

Revenue decreased 4% to $55.3 billion; revenue increased 16% excluding the impact of the previously communicated large customer contract expiration GAAP1 operating ...

Lantheus is acquiring radiopharmaceutical CDMO Evergreen Theragnostics in a deal worth up to $1 billion, expanding its manufacturing capabilities and drug pipeline. The acquisition includes Octevy, a ...

From HCLTech’s side, Ashish Kumar Gupta, Head for EMEA and corporate VP, who was instrumental in stitching the deal 2016, is ...

HCLTech aims to retain its $1 billion contract with Volvo Group as Infosys emerges as a strong contender. The negotiators met ...

Otis delivers solid fourth quarter and full year results; announces 2025 outlook with sustained earnings growth driven by continued Service momentum Fourth quarter ...